[1] 叶燕芹,许文龙. 丙型肝炎病毒感染实验室诊断进展. 标记免疫分析与临床杂志,2011,18(4):286-288. [2] Kim WR. The burden of hepatitis C in the United States.Hepatology,2002,36(5S):330-341. [3] Roffi L,Redaelli A,Colloredo G,et a1. Outcome of liver disease in a large cohort of histologically proven chronic hepatitis C:influence of HCV genotype. Eur J Gastroenterol Hepatol,2001,13(5):501-506. [4] 洪忻,喻荣彬. 丙型肝炎病毒逃避宿主免疫的机制. 世界华人消化杂志,2005,13(6):772-775. [5] 中华医学会传染病与寄生虫病学分会和肝病学分会.病毒性肝炎防治方案. 中华肝脏病杂志,2000,8(6):324-330. [6] 王鸿利. 实验诊断学. 北京:人民卫生出版社,2001:134. [7] Mssale G,Cariani E,Ferrari C. Role of viral and host factors in HCV persistence:which lesson for therapeutic and preventive strategies?Dig Liver,2004,36:703-711. [8] 何浩明. 现代肝脏疾病的实验诊断. 合肥:安徽大学出版社,2002:38-40 [9] 李卓. HCV标志物及检测. 中华检验医学杂志,2010,33(3):285-288. |